Lonestar Medicines
Boston, US · Founded 2025 · Delaware corporation · 1 known investors
Founders & leadership
NM
Naveen Manu DaryaniExecutive
WD
William Daley BonificioNamed on SEC filing
SB
Stephen Basil ThomasNamed on SEC filing
Board
AL
GH
Gianna Hoffman-LucaBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$25M disclosed across 1 round · 2026
▶$25MraisedFeb 2026 · 4 investors · BiotechnologyRule 506(b)
▶$25MraisedFeb 2026 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Naveen Manu DaryaniExecutive Officer
- Andrew LevinDirector
- William Daley BonificioExecutive Officer, Promoter
- Gianna Hoffman-LucaDirector
- Stephen Basil ThomasExecutive Officer, Director, Promoter
- Offering amount
- $45M
- Amount sold
- $25M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Lonestar Medicines's investors?
- Lonestar Medicines's investors include RA Capital.
- How much funding has Lonestar Medicines raised?
- Lonestar Medicines has disclosed $25M raised across 1 round.
- Where is Lonestar Medicines headquartered?
- Lonestar Medicines is headquartered in Boston, US.